The opening of the 21st century marked the beginning of a fundamental transformation in drug discovery made feasible by advances in genomics technologies. RNA interference now allows the identification of genes central to human disease processes through genome-wide loss-of-function screens in mammalian cells. Similarly, chemical genetic screens in mammalian cells can provide small molecules that are valuable research tools and drug leads. However, although each screening approach generates its own set of biologically important hits, the results of both types of screen are usually evaluated serially and in isolation. This approach fails to identify common pathways targeted by both types of screens. We propose to develop the experimental and analytic tools needed to identify common pathways targeted by hits from both chemical and genetic screens using high-throughput gene expression profiling. We have developed a gene expression-based high-throughput screening (GE-HTS) platform and applied it to chemical screens in primary human T cells. Expression profiling provides a """"""""common language"""""""" to characterize the molecular phenotypes not only of chemical but also of genetic manipulations. We will use GE-HTS to profile hits from parallel small-molecule and RNAi screens, and generate a compendium of signatures caused by chemical and genetic perturbations in primary human T cells. The compendium will then be mined for compounds or genes that induce similar gene expression signatures that would indicate a common target biologic pathway. 1) Identify genes essential for PD-1 inhibition using genome-scale RNA interference Hypothesis: Genes can be identified that are essential for PD-1-mediated inhibition but dispensable for J cell activation. 2) Discover small molecules that relieve PD-1 inhibition in primary human T cells using highthroughput chemical screening Hypothesis: The PD-1 signaling pathway contains proteins that can be selectively targeted by small molecules to reverse T cell inhibition. 3) Integrate chemical and genetic perturbations using high-throughput gene expression profiling to identify common biological target pathways Hypothesis: Small molecule inhibitors of a specific pathway will induce similar transcriptional signatures as genetic disruption of the same pathway.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program--Cooperative Agreements (U19)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-KS-I)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Massachusetts General Hospital
United States
Zip Code
Bengsch, Bertram; Ohtani, Takuya; Herati, Ramin Sedaghat et al. (2017) Deep immune profiling by mass cytometry links human T and NK cell differentiation and cytotoxic molecule expression patterns. J Immunol Methods :
Herati, Ramin Sedaghat; Muselman, Alexander; Vella, Laura et al. (2017) Successive annual influenza vaccination induces a recurrent oligoclonotypic memory response in circulating T follicular helper cells. Sci Immunol 2:
Stelma, Femke; van der Ree, Meike H; Sinnige, Marjan J et al. (2017) Immune phenotype and function of natural killer and T cells in chronic hepatitis C patients who received a single dose of anti-MicroRNA-122, RG-101. Hepatology 66:57-68
Huang, Alexander C; Postow, Michael A; Orlowski, Robert J et al. (2017) T-cell invigoration to tumour burden ratio associated with anti-PD-1 response. Nature 545:60-65
Wolski, David; Foote, Peter K; Chen, Diana Y et al. (2017) Early Transcriptional Divergence Marks Virus-Specific Primary Human CD8+ T Cells in Chronic versus Acute Infection. Immunity 47:648-663.e8
Chen, Zeyu; Stelekati, Erietta; Kurachi, Makoto et al. (2017) miR-150 Regulates Memory CD8 T Cell Differentiation via c-Myb. Cell Rep 20:2584-2597
Hedegaard, Ditte L; Tully, Damien C; Rowe, Ian A et al. (2017) High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end-stage liver disease. J Hepatol 66:28-38
Sise, Meghan E; Backman, Elke; Ortiz, Guillermo A et al. (2017) Effect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD. Clin J Am Soc Nephrol 12:1615-1623
Kurioka, Ayako; Jahun, Aminu S; Hannaway, Rachel F et al. (2017) Shared and Distinct Phenotypes and Functions of Human CD161++ V?7.2+ T Cell Subsets. Front Immunol 8:1031
Vergara, C; Thio, C; Latanich, R et al. (2017) Genetic basis for variation in plasma IL-18 levels in persons with chronic hepatitis C virus and human immunodeficiency virus-1 infections. Genes Immun 18:82-87

Showing the most recent 10 out of 150 publications